Journals
Publish with us
Publishing partnerships
About us
Blog
Evidence-Based Complementary and Alternative Medicine
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Evidence-Based Complementary and Alternative Medicine
/
2021
/
Article
/
Tab 3
/
Research Article
Combination of Xuesaitong and Aspirin Based on the Antiplatelet Effect and Gastrointestinal Injury: Study Protocol for a Randomized Controlled Noninferiority Trial
Table 3
Dose and duration of medication.
Group
Medication
Dose and method
Duration
Aspirin group
Enteric-coated aspirin
100 mg, q.d., oral
30 days
Xuesaitong group
Xuesaitong soft capsule
200 mg, t.i.d., oral
30 days
Drug combination group
Xuesaitong soft capsule + enteric-coated aspirin
100 mg q.d. oral aspirin and 200 mg t.i.d. oral Xuesaitong soft capsule
30 days